LLY
$67.23
Eli Lilly
($.48)
(.71%)

Earnings History

Earnings
Revenue
Reaction
Drift
2012 Below Estimates
FY 2012
1/5/2012
8:00:00 AM
$3.10 to $3.20
-1.0%
1.9%
Guidance:
Consensus:
Eli Lilly Sees 2012 Below Estimates

Eli Lilly & Co. said it expects 2011 earnings to meet or beat its previous guidance range of $4.30 to $4.35 per share. The current consensus earnings estimate is $4.34 per share for the year ending December 31, 2011. The company said it expects 2012 earnings of $3.10 to $3.20 per share on revenue of $21.8 billion to $22.8 billion. The current consensus earnings estimate is $3.58 per share on revenue of $22.78 billion for the year ending December 31, 2012.
Raises Guidance In-line with Estimates
FY 2012
4/25/2012
6:30:00 AM
$3.15 to $3.30
$21.8 bil to $22.8 bil
$3.18
$22.41 bil
2.1%
2.6%
Guidance:
Consensus:
Eli Lilly Raises Guidance, but Remains In-line with Estimates

Eli Lilly & Co. said it now expects 2012 earnings of $3.15 to $3.30 per share and continues to expect revenue of $21.8 billion to $22.8 billion. The company's previous guidance was earnings of $3.10 to $3.20 per share and the current consensus earnings estimate is $3.18 per share on revenue of $22.41 billion for the year ending December 31, 2012.
EPS Above Estimates
FY 2012
7/25/2012
6:30:00 AM
$3.30 to $3.40
$21.8 bil to $22.8 bil
$3.29
$22.69 bil
2.7%
1.4%
Guidance:
Consensus:
Eli Lilly Raises Earnings Guidance

Eli Lilly & Co. said it now expects 2012 earnings of $3.30 to $3.40 per share and continues to expect revenue of $21.8 billion to $22.8 billion. The company's previous gudiance was earnings of $3.15 to $3.30 per share per share and the current consensus earnings estimate is $3.29 per share on revenue of $22.69 billion for the year ending December 31, 2012.
Reaffirms
FY 2012
8/9/2012
8:00:00 AM
$3.30 to $3.40
$21.8 bil to $22.8 bil
$3.38
$22.7 bil
-
-
Guidance:
Consensus:
Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2012 earnings of $3.30 to $3.40 per share on revenue of $21.8 billion to $22.8 billion. The current consensus earnings estimate is $3.38 per share on revenue of $22.7 billion for the year ending December 31, 2012.
Reaffirms
FY 2012
10/24/2012
6:30:00 AM
$3.30 to $3.40
$3.40
-2.7%
-2.7%
Guidance:
Consensus:
Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2012 earnings of $3.30 to $3.40 per share. The current consensus earnings estimate is $3.40 per share for the year ending December 31, 2012.
Raises Guidance In-line with Estimates
FY 2013
1/29/2013
6:30:00 AM
$3.82 to $3.97
3.2%
2.5%
Guidance:
Consensus:
Eli Lilly Raises Guidance, but Remains In-line with Estimates

Eli Lilly & Co. said it now expects 2013 non-GAAP earnings of $3.82 to $3.97 per share and continues to expect revenue of $22.6 billion to $23.4 billion. The company's previous guidance was for earnings of $3.75 to $3.90 per share and the current consensus earnings estimate is $3.84 per share on revenue of $22.83 billion for the year ending December 31, 2013.
Reaffirms
FY 2013
4/24/2013
6:30:00 AM
$3.82 to $3.97
$22.6 bil to $23.4 bil
$3.90
$23.06 bil
-3.8%
-6.3%
Guidance:
Consensus:
Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2013 earnings of $3.82 to $3.97 per share on revenue of $22.6 billion to $23.4 billion. The current consensus earnings estimate is $3.90 per share on revenue of $23.06 billion for the year ending December 31, 2013.
EPS Above Estimates
FY 2013
7/24/2013
6:30:00 AM
$4.05 to $4.15
$22.6 bil to $23.4 bil
$3.92
$22.81 bil
3.0%
2.1%
Guidance:
Consensus:
Eli Lilly Raises Earnings Guidance

Eli Lilly & Co. said it now expects 2013 earnings of $4.05 to $4.15 per share and continues to expect revenue of $22.6 billion to $23.4 billion. The company's previous guidance was earnings of $3.82 to $3.97 per share and the current consensus earnings estimate is $3.92 per share on revenue of $22.81 billion for the year ending December 31, 2013.
Narows Guidance
FY 2013
10/23/2013
6:30:00 AM
$4.10 to $4.15
$22.6 bil to $23.4 bil
$4.12
$22.94 bil
0.3%
-2.6%
Guidance:
Consensus:
Eli Lilly Narrows Earnings Guidance

Eli Lilly & Co. said it now expects 2013 earnings of $4.10 to $4.15 per share and continues to expect revenue of $22.6 billion to $23.4 billion. The company's previous guidance was earnings of $4.05 to $4.15 per share and the current consensus earnings estimate is $4.12 per share on revenue of $22.94 billion for the year ending December 31, 2013.
In-line Guidance
FY 2014
1/7/2014
7:00:00 AM
$2.77 to $2.85
-0.7%
1.8%
Guidance:
Consensus:
Eli Lilly Sees 2014 In-line with Estimates

Eli Lilly & Co. said it expects 2014 earnings of $2.77 to $2.85 per share on revenue of $19.20 billion to $19.80 billion. The current consensus earnings estimate is $2.80 per share on revenue of $19.55 billion for the year ending December 31, 2014.
Reaffirms
FY 2014
1/30/2014
6:30:00 AM
$2.77 to $2.85
-1.2%
-2.5%
Guidance:
Consensus:
Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2014 earnings of $2.77 to $2.85 per share on revenue of $19.20 billion to $19.80 billion. The current consensus earnings estimate is $2.82 per share on revenue of $19.55 billion for the year ending December 31, 2014.
Revises Guidance with Acquisition
FY 2014
2/24/2014
8:00:00 AM
$2.72 to $2.80
$2.82
0.1%
1.6%
Guidance:
Consensus:
Eli Lilly Revises Guidance with Acquisition

Eli Lilly & Co. said with its acquisition of Lohmann SE, it now expects 2014 earnings of $2.72 to $2.80 per share. The company's previous guidance was earnings of $2.77 to $2.85 per share and the current consensus earnings estimate is $2.82 per share for the year ending December 31, 2014.
Reaffirms Below Estimates
FY 2014
4/24/2014
6:30:00 AM
$2.72 to $2.80
$2.81
-1.5%
2.2%
Guidance:
Consensus:
Eli Lilly Reaffirms Below Estimates

Eli Lilly & Co. said it continues to expect 2014 non-GAAP earnings of $2.72 to $2.80 per share. The current consensus earnings estimate is $2.81 per share for the year ending December 31, 2014.
Reaffirms
FY 2014
7/24/2014
6:30:00 AM
$2.72 to $2.80
$2.79
0.2%
-4.7%
Guidance:
Consensus:
Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2014 earnings of $2.72 to $2.80 per share. The current consensus earnings estimate is $2.79 per share for the year ending December 31, 2014.
Narrows Revenue Guidance
FY 2014
10/23/2014
6:30:00 AM
$2.72 to $2.80
$19.40 bil to $19.80 bil
$2.76
$19.77 bil
-0.5%
3.9%
Guidance:
Consensus:
Eli Lilly Narrows Revenue Guidance

Eli Lilly & Co. said it continues to expect 2014 earnings of $2.72 to $2.80 per share but now expects revenue of $19.40 billion to $19.80 billion. The company's previous guidance was revenue of $19.40 billion to $20.00 billion and the current consensus earnings estimate is $2.76 per share on revenue of $19.77 billion for the year ending December 31, 2014.
EPS In-line/Revenue Below
FY 2015
1/7/2015
7:30:00 AM
$3.10 to $3.20
-0.7%
-0.4%
Guidance:
Consensus:
Lilly Sees 2015 Revenue Below Estimates

Eli Lilly & Co. said it continues to expect 2014 non-GAAP earnings of $2.72 to $2.80 per share. The current consensus earnings estimate is $2.78 per share for the year ending December 31, 2014. The company also said it expects 2015 earnings of $3.10 to $3.20 per share on revenue of $20.3 billion to $20.8 billion. The current consensus earnings estimate is $3.16 per share on revenue of $20.88 billion for the year ending December 31, 2015.
EPS In-line/Revenue Below
FY 2015
1/30/2015
6:25:00 AM
$3.10 to $3.20
-0.2%
-3.6%
Guidance:
Consensus:
Lilly Lowers Revenue Guidance

Eli Lilly & Co. said it continues to expect 2015 earnings of $3.10 to $3.20 per share but now expects revenue of $19.5 billion to $20.0 billion. The company's previous guidance was revenue of $20.3 billion to $20.8 billion and the current consensus earnings estimate is $3.12 per share on revenue of $20.7 billion for the year ending December 31, 2015.
Reaffirms
FY 2015
4/23/2015
6:25:00 AM
$3.10 to $3.20
$19.5 bil to $20.0 bil
$3.15
$19.88 bil
0.1%
-1.4%
Guidance:
Consensus:
Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2015 earnings of $3.10 to $3.20 per share on revenue of $19.5 billion to $20.0 billion. The current consensus earnings estimate is $3.15 per share on revenue of $19.88 billion for the year ending December 31, 2015.
EPS Above Estimates
FY 2015
10/22/2015
6:25:00 AM
$3.40 to $3.45
$19.7 bil to $20.0 bil
$3.27
$19.93 bil
0.0%
6.2%
Guidance:
Consensus:
Eli Lilly Raises Guidance

Eli Lilly & Co. said it expects 2015 earnings of $3.40 to $3.45 per share on revenue of $19.7 billion to $20.0 billion. The company's previous guidance was earnings of $3.10 to $3.20 per share on revenue of $19.5 billion to $20.0 billion and the current consensus earnings estimate is $3.27 per share on revenue of $19.93 billion for the year ending December 31, 2015.
2016 Below Estimates
FY 2016
1/5/2016
6:45:00 AM
$3.45 to $3.55
1.5%
-3.0%
Guidance:
Consensus:
Eli Lilly Sees 2016 Below Estimates

Eli Lilly & Co. said it continues to expect 2015 non-GAAP earnings of $3.40 to $3.45 per share. The current consensus earnings estimate is $3.43 per share for the year ending December 31, 2015. The company also said it expects 2016 earnings of $3.45 to $3.55 per share on revenue of $20.2 billion to $20.7 billion. The current consensus earnings estimate is $3.62 per share on revenue of $21.47 billion for the year ending December 31, 2016.
Reaffirms
FY 2016
1/28/2016
6:25:00 AM
$3.45 to $3.55
-6.1%
-9.3%
Guidance:
Consensus:
Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2016 earnings of $3.45 to $3.55 per share on revenue of $20.20 billion to $20.70 billion. The current consensus earnings estimate is $3.55 per share on revenue of $20.85 billion for the year ending December 31, 2016.
Raises Guidance In-line with Estimates
FY 2016
4/26/2016
6:25:00 AM
$3.50 to $3.60
$20.60 bil to $21.10 bil
$3.55
$20.65 bil
-2.1%
-0.5%
Guidance:
Consensus:
Eli Lilly Raises Guidance, but Remains In-line with Estimates

Eli Lilly & Co. said it expects 2016 earnings of $3.50 to $3.60 per share on revenue of $20.60 billion to $21.10 billion. The company's previous guidance was earnings of $3.45 to $3.55 per share on revenue of $20.20 billion to $20.70 billion and the current consensus earnings estimate is $3.55 per share on revenue of $20.65 billion for the year ending December 31, 2016.
Reaffirms
FY 2016
7/26/2016
6:25:00 AM
$3.50 to $3.60
$20.60 bil to $21.10 bil
$3.56
$20.90 bil
0.1%
0.7%
Guidance:
Consensus:
Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2016 earnings of $3.50 to $3.60 per share on revenue of $20.60 billion to $21.10 billion. The current consensus earnings estimate is $3.56 per share on revenue of $20.90 billion for the year ending December 31, 2016.
Raises Guidance In-line with Estimates
FY 2016
10/25/2016
6:25:00 AM
$3.50 to $3.60
$20.80 bil to $21.20 bil
$3.59
$21.18 bil
0.2%
-5.1%
Guidance:
Consensus:
Eli Lilly Raises Revenue Guidance to be In-line with Estimates

Eli Lilly & Co. said it continues to expect 2016 earnings of $3.50 to $3.60 per share but now expects revenue of $20.80 billion to $21.20 billion. The company's previous guidance was revenue of $20.60 billion to $21.10 billion and the current consensus earnings estimate is $3.59 per share on revenue of $21.18 billion for the year ending December 31, 2016.
Date
Grade
Actual
Earnings
Whisper
Consensus
Estimate
Surprise
Growth
Gap
Drift
1/31/2012
6:30:00 AM
Dec '11
Q4 '11
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B-
EPS
Rev
$0.87
$6.0 Bil
$0.82
$0.81
$5.9 Bil
6.1%
2.7%
-21.6%
-2.3%
1.5%
-0.8%
4/25/2012
6:30:00 AM
Mar '12
Q1 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C+
EPS
Rev
$0.92
$5.6 Bil
-
$0.78
$5.4 Bil
17.9%
4.7%
-25.3%
-4.1%
1.2%
2.6%
7/25/2012
6:30:00 AM
Jun '12
Q2 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B-
EPS
Rev
$0.83
$5.6 Bil
$0.81
$0.77
$5.6 Bil
2.5%
0.4%
-29.8%
-10.4%
3.1%
1.4%
10/24/2012
6:30:00 AM
Sep '12
Q3 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D
EPS
Rev
$0.79
$5.4 Bil
-
$0.83
$5.6 Bil
-4.8%
-3.0%
-29.0%
-11.5%
-3.7%
-2.7%
1/29/2013
6:30:00 AM
Dec '12
Q4 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C-
EPS
Rev
$0.85
$6.0 Bil
-
$0.78
$5.8 Bil
9.0%
3.1%
-2.3%
-1.5%
0.2%
2.5%
4/24/2013
6:30:00 AM
Mar '13
Q1 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D+
EPS
Rev
$1.14
$5.6 Bil
$1.10
$1.05
$5.7 Bil
3.6%
-1.0%
21.0%
-
-0.7%
-6.3%
7/24/2013
6:30:00 AM
Jun '13
Q2 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C-
EPS
Rev
$1.16
$5.9 Bil
$1.06
$1.02
$5.8 Bil
9.4%
1.7%
35.9%
5.9%
2.0%
2.1%
10/23/2013
6:30:00 AM
Sep '13
Q3 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C-
EPS
Rev
$1.11
$5.8 Bil
-
$1.05
$5.8 Bil
5.7%
0.2%
35.2%
6.0%
0.7%
-2.6%
1/30/2014
6:30:00 AM
Dec '13
Q4 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D
EPS
Rev
$0.74
$5.8 Bil
$0.77
$0.73
$5.5 Bil
-3.9%
6.4%
-15.8%
-2.5%
0.3%
-2.5%
4/24/2014
6:30:00 AM
Mar '14
Q1 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G F
EPS
Rev
$0.70
$4.7 Bil
$0.72
$0.70
$4.8 Bil
-2.8%
-2.0%
-39.6%
-16.4%
-2.2%
2.2%
7/24/2014
6:30:00 AM
Jun '14
Q2 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D
EPS
Rev
$0.68
$4.9 Bil
$0.68
$0.66
$4.9 Bil
-
1.1%
-41.5%
-16.8%
-0.2%
-4.7%
10/23/2014
6:30:00 AM
Sep '14
Q3 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D
EPS
Rev
$0.66
$4.9 Bil
-
$0.66
$4.8 Bil
-
1.2%
-41.3%
-15.5%
-0.6%
3.9%
1/30/2015
6:25:00 AM
Dec '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C-
EPS
Rev
$0.75
$5.1 Bil
$0.74
$0.74
$5.2 Bil
1.4%
-1.5%
0.1%
-11.8%
1.3%
-3.6%
4/23/2015
6:25:00 AM
Mar '15
Q1 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C-
EPS
Rev
$0.87
$4.6 Bil
$0.77
$0.76
$4.6 Bil
13.0%
0.5%
23.2%
-0.8%
0.8%
-1.4%
7/23/2015
5:35:00 AM
Jun '15
Q2 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D-
EPS
Rev
$0.90
$5.0 Bil
-
$0.74
$4.9 Bil
21.6%
1.8%
30.2%
0.9%
3.1%
-5.1%
10/22/2015
6:25:00 AM
Sep '15
Q3 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C-
EPS
Rev
$0.89
$5.0 Bil
$0.79
$0.76
$5.0 Bil
12.7%
-0.4%
34.4%
1.7%
0.3%
6.2%
1/28/2016
6:25:00 AM
Dec '15
Q4 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D
EPS
Rev
$0.78
$5.4 Bil
$0.86
$0.77
$5.3 Bil
-9.3%
1.0%
3.8%
5.0%
0.1%
-9.3%
4/26/2016
6:25:00 AM
Mar '16
Q1 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G F
EPS
Rev
$0.83
$4.9 Bil
$0.88
$0.85
$4.8 Bil
-5.7%
0.9%
-4.5%
4.7%
-1.7%
-0.5%
7/26/2016
6:25:00 AM
Jun '16
Q2 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D-
EPS
Rev
$0.86
$5.4 Bil
$0.87
$0.85
$5.1 Bil
-1.1%
5.1%
-4.8%
8.6%
0.9%
0.7%
10/25/2016
6:25:00 AM
Sep '16
Q3 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G F
EPS
Rev
$0.88
$5.2 Bil
$0.98
$0.96
$5.4 Bil
-10.2%
-3.1%
-2.0%
4.7%
-0.9%
-5.1%
EPS
Rev
-
-
-
$0.97
$5.6 Bil
-
-
24.4%
3.2%
EPS
Rev
-
-
-
$0.89
$5.1 Bil
-
-
7.2%
4.6%
1/27/2011
$35.47
$4.74
$23.08 Bil
-
-
-
1/31/2012
$39.74
$4.41
$24.29 Bil
-7.0%
5.2%
12.0%
1/29/2013
$54.32
$3.39
$22.60 Bil
-23.1%
-6.9%
36.7%
1/30/2014
$53.27
$4.15
$23.11 Bil
22.4%
2.3%
-1.9%
1/30/2015
$72.00
$2.78
$19.62 Bil
-33.0%
-15.1%
35.2%
1/28/2016
$76.81
$3.43
$19.96 Bil
23.4%
1.7%
6.7%
1/28/2017
$67.23
$3.54
$21.03 Bil
3.2%
5.4%
-12.5%
1/28/2018
$72.72
$4.00
$22.02 Bil
13.0%
4.7%
8.2%
1/28/2019
-
$4.31
-
7.7%
-
-

Price Projection

Current Value
$67
0%
Projected Price
$73
8%